40.89
4.66%
1.82
Veracyte Inc 주식(VCYT)의 최신 뉴스
Barclays PLC Buys 85,033 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
HighTower Advisors LLC Takes $554,000 Position in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Zacks Investment Research
Veracyte CEO Marc Stapley sells shares worth $242,736 By Investing.com - Investing.com Canada
Veracyte CEO Marc Stapley sells shares worth $242,736 - Investing.com India
Lord Abbett & CO. LLC Purchases New Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte - Yahoo Finance
Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Fmr LLC - MarketBeat
US Exchange: 3 Stocks That May Be Trading Below Fair Value - Simply Wall St
Jane Street Group LLC Raises Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now - MSN
Veracyte (VCYT) Just Flashed Golden Cross Signal: Do You Buy? - MSN
Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer Diagnostics - Yahoo! Voices
Veracyte (VCYT) Shares Rebounded in Q3 - Insider Monkey
Neo Ivy Capital Management Buys Shares of 24,116 Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen - Yahoo Finance
Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68% - Yahoo Finance
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar - Yahoo Finance
Veracyte: Getting Frothy (NASDAQ:VCYT) - Seeking Alpha
Zacks Investment Management Makes New $1.12 Million Investment in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Wellington Management Group LLP Cuts Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Cerity Partners LLC Purchases New Shares in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
48,193 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by XTX Topco Ltd - MarketBeat
Verition Fund Management LLC Takes $1.32 Million Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Insider Sell Alert: Phillip Febbo Sells Shares of Veracyte Inc (VCYT) - GuruFocus.com
Veracyte's chief scientific officer sells $173,447 in stock By Investing.com - Investing.com Australia
Benjamin Edwards Inc. Boosts Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte's chief scientific officer sells $173,447 in stock - Investing.com India
Veracyte SVP McGuire sells $823,178 in stock By Investing.com - Investing.com Australia
Veracyte SVP McGuire sells $823,178 in stock - Investing.com India
Charles Schwab Investment Management Inc. Decreases Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Shares Acquired by BNP Paribas Financial Markets - MarketBeat
Veracyte's Decipher Test Makes Breakthrough: Only Gene Expression Test in 2025 NCCN Prostate Cancer Guidelines - StockTitan
Goldman Sachs Downgrades Veracyte (VCYT) - MSN
Navigating 9 Analyst Ratings For Veracyte - Benzinga
Veracyte CFO Rebecca Chambers sells $302,621 in stock By Investing.com - Investing.com South Africa
Veracyte stock downgraded by Goldman Sachs, target reduced amid slowing growth - Investing.com
Veracyte stock soars to 52-week high of $44.48 amid robust growth - Investing.com Canada
Erste Asset Management GmbH Takes $574,000 Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Veracyte's chief accounting officer sells shares worth $41,452 By Investing.com - Investing.com Australia
Veracyte CFO Rebecca Chambers sells $302,621 in stock - Investing.com
Veracyte stock soars to 52-week high of $44.48 amid robust growth By Investing.com - Investing.com South Africa
Parkman Healthcare Partners LLC Sells 80,215 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte's chief accounting officer sells shares worth $41,452 - Investing.com
VCYT (Veracyte) 3-Year Revenue Growth Rate : 31.10% (As of Sep. 2024) - GuruFocus.com
Veracyte, Inc. (NASDAQ:VCYT) Surges 25% Yet Its Low P/S Is No Reason For Excitement - Simply Wall St
PDT Partners LLC Takes $2.38 Million Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Vinva Investment Management Ltd Buys Shares of 15,266 Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
자본화:
|
볼륨(24시간):